1. Accordini S, Bugiani M, Arossa W, Gerzeli S, Marinoni A, Olivieri M, Pirina P, Carrozzi L, Dallari R, De Togni A, de Marco R (2006) Poor control increases the economic cost of asthma. A multicentre population-based study. Int Arch Allergy Immunol 141(2):189–198
2. Anonymous (2002) Diverse approaches to asthma DM succeed in Medicaid populations. Dis Manag Advis 8(5):71–77
3. Antonicelli L, Bucca C, Neri M, De Benedetto F, Sabbatani P, Bonifazi F, Eichler HG, Zhang Q, Yin DD (2004) Asthma severity and medical resource utilisation. Eur Respir J 23(5):723–729
4. Arnlind MH, Nokela M, Rehnberg C, Jonsson EW (2006) The relationship between pharmaceutical costs, disease severity, and health-related quality of life in asthmatics in Swedish primary care. J Asthma 43(8):585–591
5. Ather S, Chung KD, Gregory P, Demissie K (2004) The association between hospital readmission and insurance provider among adults with asthma. J Asthma 41(7):709–713